China FeNo Testing Market is Expected to Grow at 13.4% in the Forecast Period of 2020 to 2027

China FeNo testing business is anticipated to increase exchange germination in the projection years of 2020 to 2027 estimated to USD 43,949.48 thousand by 2027 expanding at the annual pace of 13.4% in the above-mentioned calculation years. China FeNo testing market is growing with factors such as high adoption of FeNO monitoring in reducing asthma exacerbation, along with the high cost of FeNO testing products may obstruct the growth of the market in the given forecast period.     

China FeNo Testing Market Scenario                                                         

According to Data Bridge Market Research, in the FeNo testing market Circassia is the market leader which accounts an estimated market share of approximately 40% to 50%. The company has gained outstanding sale through providing China FeNo testing.       

  • In August 2019, Bosch Healthcare Solutions GmbH (A Subsidiary of Robert Bosch GmbH) announced that they have launched the new product which is used to measure the concentration of fractional nitric oxide (FeNO). This provides the analysis of gas exhaled at home which can help in preventing diseases.

China Feno Testing MarketTrends Impacting the Market

The China FeNo testing market is becoming more competitive with companies such as Circassia, Spirosure, Inc, Medisoft Group, Sunvou, as they are the top dominating companies in China FeNo testing having maximum number of products. Data Bridge Market Research new reports highlight the major growth factors and opportunities in the China FeNo testing market.    

For more analysis on the China FeNo testing market request for a briefing with our analysts

China FeNo testing Market Development

  • In July 2015, Circassia announced that their product NIOX VERO received an approval from China Food and Drug Administration. After receiving approval from the China Food and Drug Administration, the company commercialized their product in to the market and generated more revenue by enhancing their customer base in the China.

Scope of the China FeNo Testing Market

China FeNo testing market is further analyzed based on further segmentation. China FeNo testing market on the basis of type, the market is segmented into nitric oxide handheld monitor, nitric oxide standalone monitor and others. On the basis of indication, the market is segmented into eosinophilic airway inflammation, chronic respiratory systems, corticosteroid responsiveness, atopic asthma, eosinophilic bronchitis, COPD with mixed inflammatory phenotype, cystic fibrosis, pulmonary arterial hypertension and others. On the basis of end user, the market is segmented into hospitals, clinics, diagnostic centers, homecare setting, ambulatory surgical centers and others. On the basis of distribution channel, China FeNO testing market is segmented into direct tenders, retail sales and online sales.

To know more about the study

Key Pointers Covered in China FeNo Testing Market Industry Trends and Forecast to 2027

  • Market Size
  • Top to Bottom Market Analysis
  • Recent Developments for Market Competitors
  • Recent Market Value for Different Countries
  • Impact of COVID-19 Pandemic on the Market which includes:  

    • Market Price Impact Analysis
    • Market Impact on Demand Analysis
    • Market Impact on Supply Chain Analysis
    • Market Conclusion

Key Market Competitors Covered in the Report

  • Bedfont Scientific Ltd.
  • Spirosure, Inc,
  • Medisoft Group
  • Bosch Healthcare Solutions GmbH (A Subsidiary of Robert Bosch GmbH)
  • Sunvou
  • RuiBreath
  • Circassia

Above are the key players covered in the report, to know about more and exhaustive list of China FeNo testing companies’, contact us

Research Methodology: China FeNo Testing Market

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analysed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your enquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include vendor positioning grid, market time line analysis, market overview and guide, company positioning grid, company market share analysis, standards of measurement, top to bottom analysis and vendor share analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Primary Respondents

  • Demand Side: Doctors, Healthcare Professionals, Pulmonologist  
  • Supply Side: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, and Regulatory Affairs Managers among others.

Related Reports

Browse in Healthcare Category Related Reports@